These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33961017)

  • 1. Type 2 diabetes mellitus in heterozygous familial hypercholesterolaemia: the hazardous intersection of cardiometabolic and genetic risk.
    German CA; Shapiro MD
    Eur J Prev Cardiol; 2022 Jan; 28(16):1817-1818. PubMed ID: 33961017
    [No Abstract]   [Full Text] [Related]  

  • 2. Lower diabetes rate in patients with familial hypercholesterolaemia: What is the link?
    Parhofer KG
    Eur J Prev Cardiol; 2020 Oct; 27(15):1647-1648. PubMed ID: 32054297
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia.
    Banach M; Penson PE
    Eur J Prev Cardiol; 2022 May; 29(5):718-720. PubMed ID: 33624078
    [No Abstract]   [Full Text] [Related]  

  • 4. First insights from the EAS familial hypercholesterolaemia collaboration registry: FH is still underdiagnosed and undertreated.
    Stock J
    Atherosclerosis; 2019 Nov; 290():138-139. PubMed ID: 31610884
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Commentary: What Determines the Risk of Cardiovascular Disease in Familial Hypercholesterolemia?
    Brunham LR; Mancini GBJ
    Trends Cardiovasc Med; 2021 May; 31(4):216-217. PubMed ID: 32407995
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia.
    Silva PR; Jannes CE; Marsiglia JD; Krieger JE; Santos RD; Pereira AC
    Atherosclerosis; 2016 Jul; 250():144-50. PubMed ID: 27214396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difficulties in gauging atherosclerotic cardiovascular disease risk heterogeneity in familial hypercholesterolemia.
    Mizuta MH; Santos RD
    Atherosclerosis; 2022 Oct; 358():57-59. PubMed ID: 36049962
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.
    Mundal L; Veierød MB; Halvorsen T; Holven KB; Ose L; Iversen PO; Tell GS; Leren TP; Retterstøl K
    Eur J Prev Cardiol; 2016 Dec; 23(18):1962-1969. PubMed ID: 27558979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolaemia: New directions on the diagnosis and treatment of an old disease.
    Rallidis LS; Kosmas N
    Hellenic J Cardiol; 2020; 61(6):404-406. PubMed ID: 32681886
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia.
    Liu MM; Peng J; Guo YL; Wu NQ; Zhu CG; Gao Y; Dong Q; Li JJ
    Eur J Prev Cardiol; 2022 Jan; 28(16):1807-1816. PubMed ID: 33778872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resilience of individuals with familial hypercholesterolaemia to develop atherosclerotic cardiovascular disease: lessons learned from the elderly.
    Santos RD; Coutinho ER
    Eur J Prev Cardiol; 2022 Sep; 29(12):e309-e311. PubMed ID: 34864977
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.
    Bhatnagar D; Morgan J; Siddiq S; Mackness MI; Miller JP; Durrington PN
    BMJ; 2000 Dec; 321(7275):1497-500. PubMed ID: 11118175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of early recognition of heterozygous familial hypercholesterolaemia.
    Ryan A; Byrne CD
    Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum].
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior Waluś B; Imiela J; Jankowski P; Kłosiewicz Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T;
    Kardiol Pol; 2013; 71(1):107-11. PubMed ID: 23348551
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
    Santos RD; Gidding SS; Hegele RA; Cuchel MA; Barter PJ; Watts GF; Baum SJ; Catapano AL; Chapman MJ; Defesche JC; Folco E; Freiberger T; Genest J; Hovingh GK; Harada-Shiba M; Humphries SE; Jackson AS; Mata P; Moriarty PM; Raal FJ; Al-Rasadi K; Ray KK; Reiner Z; Sijbrands EJ; Yamashita S;
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):850-61. PubMed ID: 27246162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.
    Alves AC; Alonso R; Diaz-Diaz JL; Medeiros AM; Jannes CE; Merchan A; Vasques-Cardenas NA; Cuevas A; Chacra AP; Krieger JE; Arroyo R; Arrieta F; Schreier L; Corral P; Bañares VG; Araujo MB; Bustos P; Asenjo S; Stoll M; Dell'Oca N; Reyes M; Ressia A; Campo R; Magaña-Torres MT; Metha R; Aguilar-Salinas CA; Ceballos-Macias JJ; Morales ÁJR; Mata P; Bourbon M; Santos RD
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2508-2515. PubMed ID: 32757650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    Stock JK
    Atherosclerosis; 2021 Nov; 337():57-58. PubMed ID: 34686380
    [No Abstract]   [Full Text] [Related]  

  • 20. Response by Paquette and Baass to Letter Regarding Article, "Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia".
    Paquette M; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):e526-e527. PubMed ID: 34813347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.